Clinical Trial Update: Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of doxorubicin, paclitaxel, and carboplatin in patients with primary stage III/IV or recurrent endometrial cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED